Skip to main content
. Author manuscript; available in PMC: 2013 Aug 27.
Published in final edited form as: Differentiation. 2011 Mar 17;81(4):233–242. doi: 10.1016/j.diff.2011.02.005

Figure 3.

Figure 3

Compound 1 induces Tuj1 at the expense of GFAP expression in primary Ink4a/Arf/-astrocytes. (A) Comparison of vehicle (passage 2) or 1 (passage 2 and 3) treatment in Ink4a/Arff/f and Ink4a/Arf-/- astrocytes. Note co-expression of Tuj1 and GFAP in a subset of 1-treated cells (arrows). Scale bar: 25 μm. (B-C) Quantification of Tuj1+ or GFAP+ in passage 2 or 3 astrocytes after 4 days of vehicle or 1 treatment is shown. (*p<0.05, **p < 0.001, t-test, data in graphs represent ± s.d. from three independent experiments).